Bladder cancer outcome trang 1 tải miễn phí từ tailieunhanh

"Bladder cancer outcome" trang 1 - tải miễn phí từ tailieunhanh

High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer

High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer

10 79 1

Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

9 54 1

Polymorphisms and plasma levels of IL-27: Impact on genetic susceptibility and clinical outcome of bladder cancer

Polymorphisms and plasma levels of IL-27: Impact on genetic susceptibility and clinical outcome of bladder cancer

10 50 1

Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer

Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer

11 1 1

Glycoprotein α-Subunit of Glucosidase II (GIIα) is a novel prognostic biomarker correlated with unfavorable outcome of urothelial carcinoma

Glycoprotein α-Subunit of Glucosidase II (GIIα) is a novel prognostic biomarker correlated with unfavorable outcome of urothelial carcinoma

16 17 1

Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: Data from a retrospective study

Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: Data from a retrospective study

14 67 1

Preadmission antidepressant use and bladder cancer: A population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomes

Preadmission antidepressant use and bladder cancer: A population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomes

9 46 1

Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and CIS)

Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and CIS)

1 90 0